Portfolio (Quarterly)
Guide ↗
SILVERARC CAPITAL MANAGEMENT, LLC
· CIK 0001816307| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 61 | CRNX | CRINETICS PHARMACEUTICALS IN | Healthcare | 50,000.0 | $2.1M | 0.28% | NEW | — | $41.65 | -11.7% |
| 62 | CAMP | CAMP4 THERAPEUTICS CORP | Healthcare | 653,594.0 | $2.0M | 0.26% | NEW | — | $3.00 | +52.0% |
| 63 | CTNM | CONTINEUM THERAPEUTICS INC | Healthcare | 166,161.0 | $2.0M | 0.26% | NEW | — | $11.75 | +16.8% |
| 64 | DYN | DYNE THERAPEUTICS INC | Healthcare | 100,000.0 | $1.3M | 0.17% | NEW | — | $12.65 | +36.7% |
| 65 | LBRX | LB PHARMACEUTICALS INC | Healthcare | 70,000.0 | $1.1M | 0.15% | NEW | — | $15.79 | +87.8% |
| 66 | — PUT | CAPRICOR THERAPEUTICS INC | — | 144,700.0 | $1.0M | 0.14% | NEW | — | $7.21 | — |
| 67 | — | MERSANA THERAPEUTICS INC | — | 133,636.0 | $1.0M | 0.14% | NEW | — | $7.76 | — |
| 68 | — | RADIOPHARM THERANOSTICS LTD | — | 187,406.0 | $1.0M | 0.14% | NEW | — | $5.52 | — |
| 69 | — PUT | ATYR PHARMA INC | — | 1,250,000.0 | $901K | 0.12% | NEW | — | $0.72 | — |
| 70 | IMVT | IMMUNOVANT INC | Healthcare | 50,000.0 | $806K | 0.11% | NEW | — | $16.12 | +70.5% |
| 71 | — PUT | ARCTURUS THERAPEUTICS HLDGS | — | 42,000.0 | $774K | 0.10% | NEW | — | $18.43 | — |
| 72 | — CALL | SYNDAX PHARMACEUTICALS INC | — | 50,000.0 | $770K | 0.10% | NEW | — | $15.39 | — |
| 73 | — PUT | ULTRAGENYX PHARMACEUTICAL IN | — | 25,000.0 | $752K | 0.10% | NEW | — | $30.08 | — |
| 74 | — CALL | MOONLAKE IMMUNOTHERAPEUTICS | — | 65,000.0 | $466K | 0.06% | NEW | — | $7.17 | — |
| 75 | — | MODULAR MED INC | — | 639,531.0 | $448K | 0.06% | NEW | — | $0.70 | — |
| 76 | BDSX | BIODESIX INC | Healthcare | 49,607.0 | $375K | 0.05% | NEW | — | $7.55 | +88.7% |
| 77 | MBX | MBX BIOSCIENCES INC | Healthcare | 15,000.0 | $262K | 0.04% | NEW | — | $17.50 | +85.4% |
| 78 | ELVN | ENLIVEN THERAPEUTICS INC | Healthcare | 10,675.0 | $219K | 0.03% | NEW | — | $20.47 | +102.0% |
| 79 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | 30,000.0 | $215K | 0.03% | NEW | — | $7.17 | +144.8% |
| 80 | ARCT | ARCTURUS THERAPEUTICS HLDGS | Healthcare | 3,445.0 | $63K | 0.01% | NEW | — | $18.43 | -61.9% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%